Thiard News@F4F

@newsen.bsky.social

1 day ago

Opportunities for Soleno Therapeutics Investors Amid Class Action Notice Investors in Soleno Therapeutics should note the upcoming class action aimed at those suffering significant losses during the Class Period.

Opportunities for Soleno Therapeutics Investors Amid Class Action Notice #USA #San_Francisco #Hagens_Berman #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

1 week ago

Neurocrine's Acquisition of Soleno: A New Era in Rare Disease Treatment Neurocrine Biosciences is set to acquire Soleno Therapeutics for $2.9 billion, enhancing its portfolio with the groundbreaking treatment for Prader-Willi syndrome.

Neurocrine's Acquisition of Soleno: A New Era in Rare Disease Treatment #United_States #San_Diego #Neurocrine_Biosciences #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

1 week ago

Investigation Launched After Soleno's DCCR Issues Lead to Share Value Drop A recent lawsuit against Soleno Therapeutics highlights significant investor concerns following disappointing news about its DCCR product, impacting share prices.

Investigation Launched After Soleno's DCCR Issues Lead to Share Value Drop #United_States #San_Francisco #VYKAT_XR #Soleno_Therapeutics #DCCR

Thiard News@F4F

@newsen.bsky.social

1 week ago

Investors Raise Alarm Over Soleno Therapeutics Amid Class Action Lawsuit Alleging Fraudulent Clinical Trials Investors in Soleno Therapeutics face legal action over claims of falsified clinical trial data, raising concerns about the safety of its drug DCCR. Seek compensation now.

Investors Raise Alarm Over Soleno Therapeutics Amid Class Action Lawsuit Alleging Fraudulent Clinical Trials #USA #New_York #Joseph_Levi #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Soleno Therapeutics Faces Class Action Over Troubling Drug Launch and Investor Lawsuit Soleno Therapeutics' recent drug launch has led to a significant investor lawsuit amid serious safety concerns regarding its product intended for rare genetic disorder treatment.

Soleno Therapeutics Faces Class Action Over Troubling Drug Launch and Investor Lawsuit #United_States #San_Francisco #VYKAT_XR #Soleno_Therapeutics #Hyperphagia

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Investors Seek Justice: Soleno Therapeutics Faces Class Action Over Alleged Fraud Soleno Therapeutics, Inc. faces a securities fraud lawsuit as investors claim misrepresentations about DCCR's safety. Affected shareholders may seek to lead the class action.

Investors Seek Justice: Soleno Therapeutics Faces Class Action Over Alleged Fraud #United_States #New_York #VYKAT_XR #Soleno_Therapeutics #DCCR

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

Soleno Therapeutics Confronts Legal Action as DCCR Launch Faces Troubles Soleno Therapeutics, facing a class action lawsuit, confronts challenges regarding the launch of its hyperphagia drug, DCCR, and its market impact.

Soleno Therapeutics Confronts Legal Action as DCCR Launch Faces Troubles #United_States #San_Francisco #VYKAT_XR #Soleno_Therapeutics #DCCR

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

Soleno Therapeutics Faces Securities Class Action Over DCCR Drug Launch Issues Soleno Therapeutics, Inc. is embroiled in a securities class action lawsuit following poor performance reports of its drug DCCR. Investors are encouraged to respond.

Soleno Therapeutics Faces Securities Class Action Over DCCR Drug Launch Issues #USA #Class_Action #San_Francisco #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

Investors Allege Fraud in Soleno Therapeutics Clinical Trials, Seek Class Action Status A pending class action lawsuit against Soleno Therapeutics, Inc. claims that the company's clinical trials for a key drug were flawed. Investors may pursue compensation for their losses.

Investors Allege Fraud in Soleno Therapeutics Clinical Trials, Seek Class Action Status #USA #New_York #FDA_Approval #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

Soleno Therapeutics Faces Legal Challenge Amid Launch Issues of Hyperphagia Drug VYKAT™ XR Soleno Therapeutics is under scrutiny with a class action lawsuit due to concerns regarding its newly launched hyperphagia drug, VYKAT™ XR. Investors react.

Soleno Therapeutics Faces Legal Challenge Amid Launch Issues of Hyperphagia Drug VYKAT™ XR #USA #Class_Action #San_Francisco #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

4 weeks ago

Soleno Therapeutics Faces Investor Class Action Over Drug Launch Issues Soleno Therapeutics is facing a securities class action lawsuit related to its hyperphagia drug launch disruptions, as investors report significant losses.

Soleno Therapeutics Faces Investor Class Action Over Drug Launch Issues #United_States #Class_Action #San_Francisco #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

1 month ago

Soleno Therapeutics Faces Class Action Over Hyperphagia Drug and Its Troubled Launch Soleno Therapeutics is facing a class action lawsuit concerning their hyperphagia drug launch. Investors are encouraged to share their losses as the company navigates significant challenges.

Soleno Therapeutics Faces Class Action Over Hyperphagia Drug and Its Troubled Launch #United_States #San_Francisco #VYKAT_XR #Soleno_Therapeutics #Hyperphagia

Thiard News@F4F

@newsen.bsky.social

1 month ago

Legal Challenges Mount for Soleno Therapeutics Amid Drug Launch Issues and Investor Lawsuit Soleno Therapeutics faces a securities class action lawsuit following disappointing drug launch results. Investors seek redress amid safety concerns.

Legal Challenges Mount for Soleno Therapeutics Amid Drug Launch Issues and Investor Lawsuit #United_States #Class_Action #San_Francisco #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

3 months ago

Pomerantz Law Firm Investigates Possible Securities Fraud at Soleno Therapeutics, Inc. The Pomerantz Law Firm is probing claims regarding Soleno Therapeutics, Inc. amid reports of significant stock price drops due to potential safety concerns.

Pomerantz Law Firm Investigates Possible Securities Fraud at Soleno Therapeutics, Inc. #USA #New_York #Pomerantz_Law_Firm #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

3 months ago

Pomerantz Law Firm Probes Potential Securities Fraud at Soleno Therapeutics The Pomerantz Law Firm is currently investigating claims on behalf of investors in Soleno Therapeutics, Inc. regarding potential securities fraud and adverse business practices.

Pomerantz Law Firm Probes Potential Securities Fraud at Soleno Therapeutics #United_States #New_York #Pomerantz_Law_Firm #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

4 months ago

Investor Concerns Rise as Pomerantz Law Firm Investigates Soleno Therapeutics for Fraud Allegations Pomerantz Law Firm is probing investor claims against Soleno Therapeutics, following significant stock drops after safety concerns over its product, Vykat XR.

Investor Concerns Rise as Pomerantz Law Firm Investigates Soleno Therapeutics for Fraud Allegations #USA #New_York #Pomerantz_Law #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

5 months ago

Robbins Geller Starts Investigation into Soleno Therapeutics Over Securities Violations Robbins Geller Rudman & Dowd LLP has initiated an investigation into Soleno Therapeutics for potential violations of federal securities laws, urging investors to come forward.

Robbins Geller Starts Investigation into Soleno Therapeutics Over Securities Violations #USA #Robbins_Geller #San_Diego #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

5 months ago

Soleno Therapeutics Faces Investor Backlash After VYKATÔ XR Disappointments and Stock Price Plunge Soleno Therapeutics' recent challenges with VYKAT™ XR and a sharp stock decline have prompted a detailed investigation into its communications and practices.

Soleno Therapeutics Faces Investor Backlash After VYKATÔ XR Disappointments and Stock Price Plunge #USA #San_Francisco #investor_scrutiny #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

5 months ago

Investigation Launched Into Soleno Therapeutics Amid Allegations of Securities Fraud Pomerantz LLP has initiated an investigation into Soleno Therapeutics Inc. for potential securities fraud. Stock prices have already taken a hit following critical reports.

Investigation Launched Into Soleno Therapeutics Amid Allegations of Securities Fraud #United_States #New_York #Pomerantz_LLP #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

6 months ago

Pomerantz Law Firm Investigates Possible Fraud Involving Soleno Therapeutics Investors Pomerantz LLP is examining claims for investors of Soleno Therapeutics, Inc. regarding potential securities fraud linked to their product Vykat XR.

Pomerantz Law Firm Investigates Possible Fraud Involving Soleno Therapeutics Investors #USA #New_York #Pomerantz_LLP #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

6 months ago

Pomerantz Law Firm Initiates Investigation into Soleno Therapeutics, Potential Securities Fraud Concerns Pomerantz LLP is launching an investigation on behalf of investors in Soleno Therapeutics, Inc. amid claims of potential securities fraud and illegal practices.

Pomerantz Law Firm Initiates Investigation into Soleno Therapeutics, Potential Securities Fraud Concerns #United_States #New_York #Pomerantz_LLP #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

6 months ago

Pomerantz Law Firm Launches Investigation into Soleno Therapeutics for Investor Concerns Pomerantz LLP is actively probing claims made by investors of Soleno Therapeutics after a concerning report. Discover the implications for stockholders.

Pomerantz Law Firm Launches Investigation into Soleno Therapeutics for Investor Concerns #United_States #New_York #Pomerantz_LLP #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

7 months ago

Investor Alert: Pomerantz Law Firm Probes Soleno Therapeutics for Potential Securities Fraud Pomerantz LLP is investigating allegations against Soleno Therapeutics regarding potential securities fraud, following a critical report about its product.

Investor Alert: Pomerantz Law Firm Probes Soleno Therapeutics for Potential Securities Fraud #United_States #New_York #Pomerantz_LLP #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

7 months ago

Pomerantz Law Firm Establishes Investigation into Soleno Therapeutics Amid Allegations of Misconduct Pomerantz LLP is actively investigating potential securities fraud and misconduct claims related to Soleno Therapeutics, Inc., impacting investors after a troubling report surfaced.

Pomerantz Law Firm Establishes Investigation into Soleno Therapeutics Amid Allegations of Misconduct #United_States #New_York #Pomerantz_LLP #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

7 months ago

Soleno Therapeutics Faces Scrutiny as Stock Plummets After Scorpion Report Soleno Therapeutics shares dive following a critical report by Scorpion Capital, raising concerns about its core drug, VYKAT™ XR.

Soleno Therapeutics Faces Scrutiny as Stock Plummets After Scorpion Report #USA #San_Francisco #VYKAT_XR #Soleno_Therapeutics #Scorpion_Capital

Thiard News@F4F

@newsen.bsky.social

11 months ago

LogiCare3PL Aids Launch of Soleno Therapeutics' Groundbreaking VYKAT XR Therapy LogiCare3PL proudly supports the launch of Soleno Therapeutics' VYKAT™ XR, the first FDA-approved treatment for hyperphagia linked to Prader-Willi syndrome.

LogiCare3PL Aids Launch of Soleno Therapeutics' Groundbreaking VYKAT XR Therapy #United_States #Olive_Branch #VYKAT_XR #LogiCare3PL #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

1 year ago

PANTHERx® Rare Partners with Soleno Therapeutics for VYKAT™ XR Distribution PANTHERx® Rare teams up with Soleno Therapeutics to distribute VYKAT™ XR, the first FDA-approved treatment for hyperphagia in Prader-Willi syndrome, enhancing patient care.

PANTHERx® Rare Partners with Soleno Therapeutics for VYKAT™ XR Distribution #United_States #Pittsburgh #PANTHERx_Rare #VYKAT_XR #Prader-Willi_Syndrome